Bio-Rad Laboratories BIO
$358.90 −$8.60 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $358.90 0.00%
Open$364.34
Prev close$367.50
Day range$353.31 – $369.44
Volume182.3K
Market cap$9.65B
P/E (TTM)9.5
Dividend yield–
Analyst view
ConsensusBuy
Analysts1
Average target$440.00+22.6% vs. price
- Buy 100%
Recent rating changes
The last 14 actions on file set price targets from $290.00 to $440.00, averaging $349.64.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 4 Nov 2026 | RBC Capital | BUY | $440.00 |
| 27 Sep 2026 | RBC Capital | BUY | $390.00 |
| 6 Aug 2026 | RBC Capital | BUY | $390.00 |
| 4 Aug 2026 | RBC Capital | BUY | $370.00 |
| 22 May 2026 | Wells Fargo | HOLD | $310.00 |
| 14 May 2026 | RBC Capital | BUY | $320.00 |
| 1 May 2026 | Wells Fargo | HOLD | $290.00 |
| 7 Apr 2026 | Citi | HOLD | $300.00 |
| 16 Feb 2026 | Wells Fargo | HOLD | $320.00 |
| 13 Feb 2026 | UBS | BUY | $335.00 |
| 12 Feb 2026 | Citi | BUY | $375.00 |
| 15 Dec 2025 | Wells Fargo | HOLD | $340.00 |
| 30 Oct 2025 | Wells Fargo | HOLD | $340.00 |
| 30 Oct 2025 | Citi | BUY | $375.00 |
No comments yet — be the first to weigh in on BIO.
Sign in to join the discussion.